ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • American Association for the Advancement of Science (AAAS)
  • 1985-1989  (1)
  • 1980-1984  (2)
  • 1
    Publication Date: 1982-07-23
    Description: BALB/c mice obtained commercially were found to differ significantly from the standard phenotype of BALB/c strain mice. Isoenzyme tests and H-2 haplotype analyses indicated that the majority of mice from two of the three sources tested appeared mixed, frequently heterozygous, and did not consistently express either the expected H-2 or glucose phosphate isomerase type.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Kahan, B -- Auerbach, R -- Alter, B J -- Bach, F H -- New York, N.Y. -- Science. 1982 Jul 23;217(4557):379-81.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6953593" target="_blank"〉PubMed〈/a〉
    Keywords: Animals ; Cytotoxicity Tests, Immunologic ; Female ; Flow Cytometry ; Genetic Markers ; Glucose-6-Phosphate Isomerase/genetics ; H-2 Antigens/genetics/immunology ; Inbreeding ; Lymphocytes/immunology ; Male ; Mice ; Mice, Inbred BALB C/*genetics ; Phenotype
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 1983-03-18
    Description: Rejection of mouse pancreatic islet allografts occurred in a high percentage of donor recipient combinations identical for H-21-region antigens and differing at H-2K and H-2K + H-2D without I-region disparities. The results suggest that disparities in major histocompatibility complex antigens of class I (H-2K and H-2D) alone are capable of eliciting islet allograft rejection, and that lack of a stimulus from class II (I-region) alloantigens does not ensure permanent islet allograft survival.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Morrow, C E -- Sutherland, D E -- Steffes, M W -- Najarian, J S -- Bach, F H -- AI 18326/AI/NIAID NIH HHS/ -- AI/GM 17687/AI/NIAID NIH HHS/ -- AM 13083/AM/NIADDK NIH HHS/ -- etc. -- New York, N.Y. -- Science. 1983 Mar 18;219(4590):1337-9.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6402817" target="_blank"〉PubMed〈/a〉
    Keywords: Animals ; *Graft Rejection ; H-2 Antigens/*immunology ; Histocompatibility Antigens Class II/*immunology ; *Islets of Langerhans Transplantation ; Major Histocompatibility Complex ; Mice ; T-Lymphocytes/immunology
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    Publication Date: 1986-06-13
    Description: The availability of highly specific and homogeneous antibodies to human T cells by the hybridoma technique has elicited new interest in the clinical use of antibodies to lymphocytes as immunosuppressive agents. OKT3 is the murine monoclonal antibody that has been the most widely used in clinical transplantation to induce immunosuppression. This antibody recognizes a membrane molecular complex, exclusively present on mature human T lymphocytes, which is tightly linked to the T-cell antigen receptor. The long-term therapeutic use of murine monoclonal antibodies in vivo is hampered by the intense antibody response that occurs in most human patients. Thus, when administered alone, OKT3 manifests its immunosuppressive activity only during the 10 to 15 days that precede the onset of sensitization. The results presented here show, by use of isoelectrofocusing, that the antibody response to OKT3, already reported to be restricted in its specificity (only anti-isotypic and anti-idiotypic antibodies are produced), is in addition oligoclonal. This restriction of the anti-monoclonal response may suggest that an efficient way to circumvent the sensitization problem would be to administer consecutively different monoclonal antibodies presenting the same specificity but distinct idiotypes.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Chatenoud, L -- Jonker, M -- Villemain, F -- Goldstein, G -- Bach, J F -- New York, N.Y. -- Science. 1986 Jun 13;232(4756):1406-8.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/3086976" target="_blank"〉PubMed〈/a〉
    Keywords: Antibodies, Monoclonal/*immunology/therapeutic use ; Antibody Formation ; Antibody Specificity ; Antigens, Differentiation, T-Lymphocyte ; Antigens, Surface/immunology ; Clone Cells/immunology ; Humans ; Immunoglobulin Idiotypes/immunology ; Immunosuppressive Agents ; T-Lymphocytes/*immunology
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...